An update from Arcadia Biosciences (RKDA) is now available.
Arcadia Biosciences, Inc. has elevated Thomas J. Schaefer to a Class I director position following Stanley Jacot’s resignation. Schaefer, who has been with Arcadia since 2020 and its president and CEO since 2022, brings a robust financial background to the role, including a past as a finance director in the food industry and an equity research analyst. His academic credentials include a BBA and an MBA from prestigious institutions, underscoring his expertise in economics and finance.
See more data about RKDA stock on TipRanks’ Stock Analysis page.
